Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (32 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Dec 2021 – 20 Aug 2026, limited by Bandhan Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Multi Cap Fund | Nifty 500 |
|---|---|---|
| 03 Dec 2021 | ₹100.00 | ₹100.00 |
| 25 Apr 2022 | ₹99.90 | ₹98.77 |
| 16 Sep 2022 | ₹106.90 | ₹102.61 |
| 06 Feb 2023 | ₹108.76 | ₹100.52 |
| 30 Jun 2023 | ₹120.60 | ₹110.59 |
| 20 Nov 2023 | ₹131.92 | ₹118.29 |
| 12 Apr 2024 | ₹157.36 | ₹139.64 |
| 02 Sep 2024 | ₹184.41 | ₹159.94 |
| 23 Jan 2025 | ₹166.78 | ₹144.98 |
| 16 Jun 2025 | ₹180.72 | ₹155.46 |
| 06 Nov 2025 | ₹183.41 | ₹158.27 |
| 30 Mar 2026 | ₹160.63 | ₹138.18 |
| 20 Aug 2026 | ₹190.23 | ₹158.27 |
| Metric | Bandhan · Direct NAV ₹19.04 Very High risk ★★★☆☆ | Category median Multi Cap Fund · 32 funds |
|---|---|---|
| +4.33% | +9.70% | |
| +15.19% | +16.81% | |
| — | +15.89% | |
| — | +15.33% | |
| +14.62% | +16.56% | |
| +13.96% | — | |
| +18.90% | +18.65% | |
| — | +16.76% | |
| — | +16.70% | |
| Risk | ||
| 13.64% | 14.82% | |
| 0.64 | 0.64 | |
| 0.86 | 0.87 | |
| -18.30% | -20.01% | |
| Nifty 500 | — | |
| +2.49% | +4.32% | |
| 1.00 | 1.01 | |
| 105.4% | 111.5% | |
| 92.7% | 92.7% | |
| 0.95% | 0.94% | |
| ₹2,886Cr | ₹3,392Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 57% | 57% | |
| Harshal Joshi | — | |
| 03 Dec 2021 | — | |
| 111 | — | |
| 28.2% | — | |
| 3.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.